Novartis (NVS) Earnings Date, Estimates & Call Transcripts

$115.81

-0.16 (-0.14%)

(As of 09:58 AM ET)

Upcoming Earnings Date: Oct. 29
Before Market Opens
Confirmed
Actual EPS (Jul. 18): $1.97 Beat By $0.10
Consensus EPS (Jul. 18): $1.87

NVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Monetary Gold

Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

Novartis Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	$1.71	$1.71	$1.71
Q2 2024	1	$1.80	$1.80	$1.80
Q3 2024	1	$1.88	$1.88	$1.88
Q4 2024	1	$1.86	$1.86	$1.86
FY 2024	4	$7.25	$7.25	$7.25
Q1 2025	1	$1.92	$1.92	$1.92
Q2 2025	1	$2.07	$2.07	$2.07
Q3 2025	1	$2.19	$2.19	$2.19
Q4 2025	1	$2.07	$2.07	$2.07
FY 2025	4	$8.25	$8.25	$8.25
Q1 2026	1	$2.03	$2.03	$2.03
Q2 2026	1	$2.24	$2.24	$2.24

NVS Earnings Date and Information

Novartis last announced its earnings results on July 18th, 2024. The reported $1.97 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.10. The company earned $12.87 billion during the quarter, compared to the consensus estimate of $12.24 billion. Novartis has generated $7.41 earnings per share over the last year ($7.41 diluted earnings per share) and currently has a price-to-earnings ratio of 15.7. Earnings for Novartis are expected to grow by 10.53% in the coming year, from $7.50 to $8.29 per share. Novartis has confirmed that its next quarterly earnings report will be published on Tuesday, October 29th, 2024.

Novartis Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/29/2024 (Confirmed)	-	-	-	-	-	-	-
7/18/2024	Q2 2024	$1.87	$1.97	+$0.10	$2.35	$12.24 billion	$12.87 billion
4/23/2024	Q1 2024	$1.73	$1.80	+$0.07	$2.29	$11.50 billion	$11.83 billion
1/30/2024	Q4 2023	$1.64	$1.53	($0.11)	($1.08)	$11.69 billion	$11.42 billion
10/23/2023	Q3 2023	$1.70	$1.74	+$0.04	$2.63	$12.05 billion	$11.78 billion
7/19/2023	Q2 2023	$1.68	$1.83	+$0.15	$2.55	$6.32 million	$13.62 billion
4/25/2023	Q1 2023	$1.55	$1.71	+$0.16	$2.34	$12.60 billion	$12.95 billion
Get the Latest News and Ratings for NVS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novartis and its competitors with MarketBeat's FREE daily newsletter.
2/1/2023	Q4 2022	$1.42	$1.51	+$0.09	$2.34	$12.85 billion	$12.69 billion
10/25/2022	Q3 2022	$1.57	$1.58	+$0.01	$2.44	$12.90 billion	$12.54 billion
7/19/2022	Q2 2022	$1.51	$1.56	+$0.05	$2.35	$12.78 billion	$12.78 billion
4/26/2022	Q1 2022	$1.44	$1.46	+$0.02	$1.92	$12.61 billion	$12.53 billion
2/2/2022	Q4 2021	$1.44	$1.40	($0.04)	($4.44)	$13.25 billion	$13.23 billion
10/25/2021	Q3 2021	$1.65	$1.71	+$0.06	$2.20	$13.02 billion	$13.03 billion
7/20/2021	Q2 2021	$1.52	$1.66	+$0.14	$2.00	$12.41 billion	$12.96 billion
4/26/2021	Q1 2021	$1.54	$1.52	($0.02)	$2.13	$12.63 billion	$12.41 billion
1/25/2021	Q4 2020	$1.37	$1.34	($0.03)	$1.76	$12.86 billion	$12.77 billion
11/1/2020	Q3 2020	$1.45	$1.52	+$0.07	$2.20	$12.58 billion	$12.26 billion
7/21/2020	Q2 2020	$1.31	$1.36	+$0.05	$1.89	$11.77 billion	$11.35 billion
4/28/2020	Q1 2020	$1.37	$1.56	+$0.19	$2.15	$11.92 billion	$12.28 billion
1/29/2020	Q4 2019	$1.32	$1.31	($0.01)	$2.13	$12.49 billion	$12.40 billion
10/22/2019	Q3 2019	$1.31	$1.41	+$0.10	$1.93	$11.67 billion	$12.17 billion

Novartis Earnings - Frequently Asked Questions

When is Novartis's earnings date?: Novartis has confirmed that its next quarterly earnings data will be published on Tuesday, October 29th, 2024. Learn more on NVS's earnings history.
Did Novartis beat their earnings estimates last quarter?: In the previous quarter, Novartis (NYSE:NVS) reported $1.97 earnings per share (EPS) to beat the analysts' consensus estimate of $1.87 by $0.10. Learn more on analysts' earnings estimate vs. NVS's actual earnings.
How can I listen to Novartis's earnings conference call?: The conference call for Novartis's latest earnings report can be listened to online. Listen to Conference Call
How can I read Novartis's conference call transcript?: The conference call transcript for Novartis's latest earnings report can be read online. Read Transcript
How much revenue does Novartis generate each year?: Novartis (NYSE:NVS) has a recorded annual revenue of $48.86 billion.
How much profit does Novartis generate each year?: Novartis (NYSE:NVS) has a recorded net income of $14.85 billion. NVS has generated $7.41 earnings per share over the last four quarters.
What is Novartis's price-to-earnings ratio?: Novartis (NYSE:NVS) has a trailing price-to-earnings ratio of 15.65 and a forward price-to-earnings ratio of 15.47. The price/earnings-to-growth ratio is 1.73.
What is Novartis's EPS forecast for next year?: Novartis's earnings are expected to grow from $7.50 per share to $8.29 per share in the next year, which is a 10.53% increase.